MXCT vs ORCL · rev $38.6M vs P/E 31, rev $67.36B
MaxCyte Inc (MXCT) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
MXCT currently screens at market cap $124.3M. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the MXCT and ORCL stock pages for the full models.
Not investment advice.